Neuropsychiatric alterations in MDMA users: Preliminary findings

Annals of the New York Academy of Sciences

Volumn 1053, Issue , 2005, Pages 20-27

  Herning, Ronald I ^a   Better, Warren ^a   Tate, Kimberly ^a   Cadet, Jean L ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

Author keywords

Cerebral perfusion deficits; Ecstasy; EEG deficits; Marijuana; MDMA; Medical complications; Polysubstance abuse; Transcranial Doppler

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; ALCOHOL; CANNABIS;

ADULT; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CANNABIS ADDICTION; CHRONIC DISEASE; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DOPPLER ECHOGRAPHY; DRUG ABUSE; ELECTROENCEPHALOGRAM; FEMALE; FOURIER TRANSFORMATION; HUMAN; MALE; MIDDLE CEREBRAL ARTERY; NEUROPATHOLOGY; NEUROPSYCHIATRY;

CANNABIS; CANNABIS SATIVA;

EID: 29744437016     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1344.003     Document Type: Conference Paper

References (35)

1. BANKEN, J.A. 2004. Drug abuse trends among youth in the United States. Ann. N.Y. Acad. Sci. 1025: 465-471.
2. HUETHER, G., D. ZHOU & E. RUTHER. 1997. Long-term modulation of presynaptic 5-HT-output: experimentally induced changes in cortical 5-HT-transporter density, tryptophan hydroxylase content, and 5-HT innervation density. J. Neural. Transm. 104: 993-1004.
3. RICAURTE, G.A., L.E. DELANNEY, S.G. WIENER et al. 1988. 5-Hydroxyindoleacetic acid in cerebrospinal fluid reflects serotonergic damage induced by 3,4-methylenedioxymethamphetamine in CNS of non-human primates. Brain Res. 474: 359-363.
4. SCHEFFEL, U., J.R. LEVER, M. STATHIS & G.A. RICAURTE. 1992. Repeated administration of MDMA causes transient down-regulation of serotonin 5-HT2 receptors. Neuropharmacology 31: 881-893.
5. BENAZZI, F. & M. MAZZOLI. 1991. Psychiatric illness associated with "ecstasy". Lancet 338: 1520.
6. PALLANTI, S. & D. MAZZI. 1992. MDMA (ecstasy) precipitation of panic disorder. Biol. Psychiatry 32: 91-95.
7. THEUNE, M., W. ESSER, K.E DRUSCHKY et al. 1999. Grand mal series after ecstasy abuse. Nervenarzt 70: 1094-1097.
8. FINSTERER, J., C. STOLLBERGER, C. STEGER & A. KROISS. 2003. Long lasting impaired cerebral blood flow after ecstasy intoxication. Psychiatry Clin. Neurosci. 57: 221-225.
9. RENEMAN, L., J.B. HABRAKEN, C.B. MAJOIE et al. 2000. MDMA ("ecstasy") and its association with cerebrovascular accidents: preliminary findings. Am. J. Neuroradiol. 21: 1001-1007.
10. BOLLA, K.I., U.D. MCCANN & G.A. RICAURTE. 1998. Memory impairment in abstinent MDMA ("ecstasy") users. Neurology 51: 1532-1537.
11. WAREING, M., J.E. FISK, P. MURPHY & C. MONTGOMERY. 2004. Verbal working memory deficits in current and previous users of MDMA. Hum. Psychopharmacol. 19: 225-234.
12. MCCANN, U.D., M. MERTL, V. ELIGULASHVILI & G.A. RICAURTE. 1999. Cognitive performance in (±)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") users: a controlled study. Psychopharmacology (Berl.) 143: 417-425.
13. GAMMA, A., A. BUCK, T. BERTHOLD & F.X. VOLLENWEIDER. 2001. No difference in brain activation during cognitive performance between ecstasy (3,4-methylenedioxymethamphetamine) users and control subjects: a [H2(15)O]-positron emission tomography study. J. Clin. Psychopharmacol. 21: 66-71.
14. CHANG, L, C.S. GROB, T. ERNST et al. 2000. Effect of ecstasy [3,4-methylenedioxymethamphetamine (MDMA)] on cerebral blood flow, a co-registered SPECT and MRI study. Psychiatry Res. 98: 15-28.
15. BUCHERT, R., J. OBROCKI, R. THOMASIUS et al. 2001. Long-term effects of "ecstasy" abuse on the human brain studied by FDG PET. Nucl. Med. Commun. 22: 889-897.
16. MOELLER, F.G., J.L. STEINBERG, G.M. DOUGHERTY et al. 2004. Functional MRI study of working memory in MDMA users. Psychopharmacology (Berl.) 177: 185-194.
17. DAUMANN, J., JR., T. FISCHERMANN, K. HEEKEREN et al. 2004. Neural mechanisms of working memory in ecstasy (MDMA) users who continue or discontinue ecstasy and amphetamine use: evidence from an 18-month longitudinal functional magnetic resonance imaging study. Biol. Psychiatry 56: 349-355.
18. DAFTERS, R.I., F. DUFFY, P.J. O'DONNELL & C. BOUQUET. 1999. Level of use of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in humans correlates with EEG power and coherence. Psychopharmacology (Berl.) 145: 82-90.
19. GAMMA, A., E. FREI, D. LEHMANN et al. 2000. Mood state and brain electric activity in ecstasy users. Neuroreport 11: 157-162.
20. PARROTT, A.C., E. SISK & J.J. TURNER. 2000. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend. 60: 105-110.
21. RODGERS, J. 2000. Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology (Berl.) 151: 19-24.
22. CROFT, R.J., A. KLUGMAN, T. BALDEWEG & J.H. GRUZELIER. 2001. Electrophysiological evidence of serotonergic impairment in long-term MDMA ("ecstasy") users. Am. J. Psychiatry 158: 1687-1692.
23. SIMON, N.G. & R.P. MATTICK. 2002. The impact of regular ecstasy use on memory function. Addiction 97: 1523-1529.
24. DAFTERS, R.I., R. HOSHI & A.C. TALBOT. 2004. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long-term polydrug users. Psychopharmacology (Berl.) 173: 405-410.
25. BOYD, C.J., S.E. MCCABE & H. D'ARCY. 2003. Ecstasy use among college undergraduates: gender, race, and sexual identity. J. Subst. Abuse Treat. 24: 209-215.
26. SINGER, L.T., T.L. LINARES, S. NTIRI et al. 2004. Psychosocial profiles of older adolescent MDMA users. Drug Alcohol Depend. 74: 245-252.
27. DAUMANN, J., S. PELZ, S. BECKER et al. 2001. Psychological profile of abstinent recreational ecstasy (MDMA) users and significance of concomitant cannabis use. Hum. Psychopharmacol. 16: 627-633.
28. FISK, J.E., C. MONTGOMERY, P. MURPHY & M. WAREING. 2004. Evidence for executive deficits among users of MDMA (ecstasy). Br. J. Psychol. 95: 457-466.
29. ROBINS, L.N., L. COTTLER, K. BUCHOLZ & W. COMPTON. 1995. Diagnostic Interview Schedule for DSM-IV. Washington University Press. St. Louis.
30. MCLELLAN, A.T., L. LUBORSKY, J. CACCIOLA et al. 1986. Guide to the Addiction Severity Index: Background, Administration, and Field Testing Results. National Institute on Drug Abuse, Treatment Research Reports. Rockville, MD.
31. DEROGATIS, L.R. 1983. Administration, Scoring, and Procedures for SCL-90R: Manual II. Clinical Psychometric Research. Towson, MD.
32. GREENHOUSE, S.W. & S. GEISSER. 1959. On methods in the analysis of profile data. Psychometrika 24: 95-112.
33. STRUVE, F.A., J.J. STRAUMANIS, G. PATRICK et al. 1999. Topographic quantitative EEG sequelae of chronic marihuana use: a replication using medically and psychiatrically screened normal subjects. Drug Alcohol Depend. 56: 167-179.
34. BRUNOVSKY, M., M. MATOUSEK, A. EDMA et al. 2003. Objective assessment of the degree of dementia by means of EEG. Neuropsychobiology 48: 19-26.
35. SATTEL, H., S. BIEDERT & H. FORSTL. 1996. Senile dementia of Alzheimer type and multi-infarct dementia investigated by transcranial Doppler. Dementia 7: 41-46.